Clinical Trials Browser

NCT03520660 2026-05-22

People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents

Phase 4 Active not recruiting

121 enrolled

Gastrointestinal

Cardiovascular Diseases, Diabetes Mellitus, Fibrosis, Hepatitis C, Carcinoma, Hepatocellular, Hepatitis C, Chronic

NCT01082419 2026-05-14

NARFI

Phase NA Completed

109 enrolled

Gastrointestinal

Digestive System Diseases, Fibrosis, Heart Failure, Carcinoma, Hepatocellular, Liver Cirrhosis

NCT05027425 2026-05-06

Durvalumab (MEDI4736) and Tremelimumab for Hepatocellular Carcinoma in Patients Listed for a Liver Transplant

Phase 2 Terminated

8 enrolled 9 charts

Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular, Hypertension, Portal

NCT02908048 2026-05-05

Extracellular RNA Markers of Liver Disease and Cancer

Terminated

1,865 enrolled

Gastrointestinal

Bile Duct Neoplasms, Biliary Tract Neoplasms, Fibrosis, Hepatitis, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Cholangiocarcinoma

NCT02968810 2026-05-04

Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis

Phase 2 Active not recruiting

52 enrolled 15 charts

Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular

NCT06096779 2026-05-04

Kirros

Phase 2 Recruiting

30 enrolled

Gastrointestinal

Digestive System Neoplasms, Fatty Liver, Fibrosis, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms

NCT02626312 2026-04-30

Radiation Therapy in Treating Patients With Hepatocellular Carcinoma, Cholangiocarcinoma, or Liver Metastasis Who Have Impaired Liver Function

Phase 1 Active not recruiting

36 enrolled

Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular, Cholangiocarcinoma

NCT05637216 2026-04-24

Losartan to Reduce Radiation Induced Fibrosis in Breast Cancer Patients

Phase 2 Recruiting

43 enrolled

Breast

Radiation Fibrosis Syndrome, Breast Neoplasms, Camurati-Engelmann Syndrome, Fibrosis, Inflammation

NCT03612531 2026-04-23

MANTLE

Phase NA Active not recruiting

24 enrolled

Deglutition Disorders, Fibrosis

NCT05486572 2026-04-21

PREMIUM

Phase NA Recruiting

4,700 enrolled

Gastrointestinal

Chronic Disease, Fibrosis, Carcinoma, Hepatocellular, Liver Neoplasms, Neoplasms

NCT07529262 2026-04-14

AspiRe HCC

Phase 3 Not yet recruiting

890 enrolled

Carcinoma, Fibrosis, Liver Cirrhosis, Neoplasms

NCT05263362 2026-04-13

STARLINGS

Completed

775 enrolled

Breast

Breast Carcinoma In Situ, Breast Neoplasms, Fibrosis

NCT05874492 2026-04-13

FIBROTHERME

Phase NA Recruiting

110 enrolled

BreastHead & Neck

Breast Neoplasms, Fibrosis, Head and Neck Neoplasms

NCT04620538 2026-03-30

VOCAL

Completed

56 enrolled

Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular, Liver Cirrhosis, Liver Neoplasms

NCT05586516 2026-03-30

A Study to Assess an ATX Inhibitor (IOA-289) in Patients With Metastatic Pancreatic Cancer

Phase 1/2 Completed

16 enrolled

Gastrointestinal

Fibrosis, Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms

NCT07469319 2026-03-13

BISHOP

Phase NA Recruiting

617 enrolled

Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular

NCT05095714 2026-03-12

FASTRAK

Phase NA Recruiting

944 enrolled

Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular, Liver Neoplasms

NCT07010315 2026-03-04

Development and Testing of a Patient-facing Educational Tool About Liver Cancer Prevention

Recruiting

40 enrolled

Gastrointestinal

Fibrosis, Liver Diseases, Liver Neoplasms